Modern chemical enterprise group integrating scientific research, production and sales. The company focuses on the production, sales and application services of agrochemicals, catalysts, plastic additives, coating additives, food chemistry and pharmaceutical intermediates.
Pros:
The listing includes standard chemical identifiers – CAS number, molecular formula, molecular weight, appearance, solubility, etc., which suggests that the supplier is aware of and provides standard chemical specifications.
FSCICHEM offers global supply and appears to support bulk packaging, which may suit needs if purchasing larger quantities.
Cons:
Although the product is listed under a category that includes “Food Pharmaceutical Chemicals,” the actual grade for sodium dichloroacetate is specified as “Industrial grade / cosmetic grade” – not “pharmaceutical grade” or “research-grade.” That signals a lack of guarantee for purity beyond nominal assay, and increases uncertainty regarding batch consistency or suitability for medical or therapeutic use.
There is no readily accessible Certificate of Analysis (CoA) or independently verifiable documentation linked on the product page; this diminishes confidence in verifying actual impurity levels, contaminants (heavy metals, solvents, etc.), or batch-to-batch variability.
The product is offered alongside industrial chemicals, plastics additives, agricultural chemicals and water-treatment chemicals – i.e., the company appears to prioritise industrial/commercial uses rather than strictly research or pharmaceutical applications.
Summary (3/5 Stars)
FSCICHEM appears to be a legitimate chemical manufacturer/distributor that delivers sodium dichloroacetate with acceptable nominal purity and bulk-supply capacity – likely suitable for industrial, Synthesis, or non-critical laboratory applications.
However, because of the lack of transparent quality documentation, the ambiguous grade classification, and absence of explicit assurance for pharmaceutical/research-grade standards.
Their DCA might be usable in low-risk or exploratory settings, but for anything clinically relevant, more rigorous sourcing would be needed.